S. Marciniak (Cambridge (Cambridgeshire), United Kingdom), A. Joannes (RENNES, France)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Mapping of Kras mutations during chemical carcinogenesis
S. Behrend (Munich, Germany), M. Spella (Rio, Greece), M. Pepe (Munich, Germany), G. Giotopoulou (Munich, Germany), M. Lianou (Rio, Greece), I. Giopanou (Rio, Greece), A. Lamort (Munich, Germany), G. Stathopoulos (Munich, Germany)
|   |
Differential expression analysis of lncRNA in different types of lung cancer
M. Arroyo Varela (Málaga, Spain), L. Aguilera Cobos (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), M. Claros Díaz (Málaga, Spain), R. Bautista Moreno (Málaga, Spain)
| |
The analysis of CHEK2 gene mutation in small cell lung cancer
A. Nizamova (Ufa, Russian Federation), G. Gimalova (Ufa, Russian Federation), Z. Abdullin (Ufa, Russian Federation), E. Khusnutdinova (Ufa, Russian Federation)
| |
Mutational RNA signatures in environmentally-induced lung adenocarcinoma
G. Giotopoulou (Munich, Germany), S. Behrend (Munich, Germany), G. Ntaliarda (Patras, Greece), A. Lamort (Munich, Germany), M. Pepe (Munich, Germany), I. Lillis (Patras, Greece), M. Spella (Patras, Greece), G. Stathopoulos (Munich, Germany)
| |
Altered expression of long non-coding RNA in sputum and blood during pulmonary exacerbation in cystic fibrosis
Z. Stachowiak (Poznan, Poland), B. Narozna (Poznan, Poland), W. Langwinski (Poznan, Poland), I. Wojsyk-Banaszak (Poznan, Poland), K. Jonczyk Potoczna (Poznan, Poland), A. Breborowicz (Poznan, Poland), A. Szczepankiewicz (Poznan, Poland)
| |
Airway remodelling augmented in patients with asthma COPD overlap (ACO) compared to asthma and COPD.
S. Dey (Tasmania, Australia), W. Lu (Tasmania, Australia), J. Markos (Tasmania, Australia), J. Larby (Tasmania, Australia), C. Chia (Tasmania, Australia), G. Haug (Tasmania, Australia), H. Weber (Tasmania, Australia), S. Brake (Tasmania, Australia), S. Myers (Tasmania, Australia), A. Gaikwad (Tasmania, Australia), P. Bhattarai (Tasmania, Australia), P. Wark (Newcastle, Australia), M. Eapen (Tasmania, Australia), S. Sohal (Tasmania, Australia)
| |
Potential translation of plasma microRNA signatures in the risk stratification of COVID-19 patients admitted to the ICU
I. Benítez (Lleida / Lérida, Spain), A. Carratalá (Lleida / Lérida, Spain), A. Moncusí-Moix (Lleida / Lérida, Spain), C. Gort-Paniello (Lleida / Lérida, Spain), L. Pinilla (Lleida / Lérida, Spain), M. Molinero (Lleida / Lérida, Spain), J. González (Lleida / Lérida, Spain), G. Torres (Lleida / Lérida, Spain), M. Bernal (Lleida / Lérida, Spain), S. Pico (Lleida / Lérida, Spain), R. Almansa (Madrid, Spain), N. Jorge (Madrid, Spain), A. Ortega (Madrid, Spain), E. Bustamante-Munguira (Madrid, Spain), J. Gómez (Madrid, Spain), M. González-Rivera (Madrid, Spain), D. Micheloud (Madrid, Spain), P. Ryan (Madrid, Spain), A. Martínez (Madrid, Spain), L. Tamayo (Madrid, Spain), C. Aldecoa (Madrid, Spain), R. Ferrer (Madrid, Spain), A. Ceccato (Madrid, Spain), L. Fernández (Madrid, Spain), A. Motos (Madrid, Spain), J. Riera (Madrid, Spain), R. Menéndez (Madrid, Spain), D. Garcia-Gasulla (Madrid, Spain), Ó. Peñuelas (Madrid, Spain), A. Torres (Madrid, Spain), J. Bermejo-Martin (Madrid, Spain), F. Barbé (Lleida / Lérida, Spain), D. de Gonzalo Calvo (Lleida / Lérida, Spain)
| |
Alterations of systemic hyaluronic acid in patients with COPD: a cross-sectional analysis
K. Waeijen-Smit (Horn, Netherlands), N. Reynaert (Maastricht, Netherlands), R. Beijers (Maastricht, Netherlands), S. Houben-Wilke (Horn, Netherlands), S. Simons (Maastricht, Netherlands), M. Spruit (Horn, Netherlands), F. Franssen (Horn, Netherlands)
| |
Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients
L. Bañuls (Valencia, Spain), S. Castillo (Valencia, Spain), M. Magallón (Valencia, Spain), D. Pellicer (Valencia, Spain), S. Bondia (Valencia, Spain), M. Navarro-García (Valencia, Spain), C. González (Valencia, Spain), F. Dasí (Valencia, Spain)
| |
Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis
K. Wolffs (Cardiff, United Kingdom), D. Pass (Cardiff, United Kingdom), B. Mansfield (Cardiff, United Kingdom), R. Bruce (Cardiff, United Kingdom), P. Popov (Cardiff, United Kingdom), C. Corrigan (London, United Kingdom), J. Ward (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), B. Hope-Gill (Cardiff, United Kingdom), D. Riccardi (Cardiff, United Kingdom)
| |
Genetic risk for covid-19 outcomes in COPD
R. Marçalo (Aveiro, Portugal), S. Neto (Aveiro, Portugal), M. Pinheiro (Aveiro, Portugal), A. Rodrigues (Braga, Portugal), N. Sousa (Braga, Portugal), M. Santos (Aveiro, Portugal), P. Simão (Porto, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal), G. Moura (Aveiro, Portugal)
| |
Accelerated analysis of reactivation of the dormant Mycobacterium tuberculosis using mycobacteriophage D29.
M. Vladimirsky (Moscow, Russian Federation), M. Lapenkova (Moscow, Russian Federation), G. Arustamova (Moscow, Russian Federation), I. Granovsky (Moscow, Russian Federation), A. Makarova (Moscow, Russian Federation), R. Kuznitsyn (Moscow, Russian Federation)
| |
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients
s. pavanello (Padova, Italy), M. Campisi (Padova, Italy), F. Liviero (Padova, Italy), D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), P. Spagnolo (Padova, Italy)
| |
Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients.
A. Mariscal (Barcelona, Spain), L. Alserawan (Barcelona, Spain), I. Castellví (Barcelona, Spain), E. Ortiz (Barcelona, Spain), P. Peñacoba (Barcelona, Spain), T. Franco-Leyva (Barcelona, Spain), J. Tandaipán (Barcelona, Spain), L. Martínez-Martínez (Barcelona, Spain), H. Corominas (Barcelona, Spain), P. Domingo (Barcelona, Spain), C. Juárez (Barcelona, Spain), D. Castillo (Barcelona, Spain)
| |
Comparison of transcriptional differences between IL-4Ra and IL-5 blockade in a mouse model of asthma
G. Scott (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), S. Asrat (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), K. Nagashima (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), S. Srivatsan (Tarrytown, United States of America), D. Ajithdoss (Tarrytown, United States of America), A. Oyejide (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), J. Walls (Tarrytown, United States of America), A. Le Floc'H (Tarrytown, United States of America), G. Yancopoulos (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America)
| |
The worldwide covid-19 genetic risk scenario
R. Marçalo (Aveiro, Portugal), S. Neto (Aveiro, Portugal), M. Pinheiro (Aveiro, Portugal), A. Rodrigues (Braga, Portugal), N. Sousa (Braga, Portugal), M. Santos (Aveiro, Portugal), P. Simão (Porto, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal), G. Moura (Aveiro, Portugal)
| |
Saliva as a “patient-friendly” specimen for COPD assessment
A. Sousa (Aveiro, Portugal), S. Melo-Dias (Aveiro, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal)
| |
Evolution of tetracycline resistant S. aureus in hypoxia
R. Hull (Sheffield, United Kingdom), S. Foster (Sheffield, United Kingdom), M. Brockhurst (Manchester, United Kingdom), A. Condliffe (Sheffield, United Kingdom)
| |